Bendamustine/Idelalisib/Rituximab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of bendamustine, idelalisib and rituximab that can be used in the treatment of relapsed/refractory chronic lymphocytic leukemia (CLL).

**Synonyms:** - BR and Idelalisib - Bendamustine and Rituximab (BR) and Idelalisib - Bendamustine and Rituximab-abbs (BR) and Idelalisib - Bendamustine and Rituximab-arrx (BR) and Idelalisib - Bendamustine and Rituximab-blit (BR) and Idelalisib - Bendamustine and Rituximab-pvvr (BR) and Idelalisib - Bendamustine and Rituximab-rite (BR) and Idelalisib - Bendamustine and Rituximab-rixa (BR) and Idelalisib - Bendamustine and Rituximab-rixi (BR) and Idelalisib - Bendamustine/Idelalisib/Rituximab - IBR - IBR Regimen - Idelalisib/Bendamustine/Rituximab - Idelalisib/Bendamustine/Rituximab Regimen